Breast Cancer in Men – a ‘rare’ disease that kills more than testicular cancer!

Breast Cancer in Men – a ‘rare’ disease that kills more than testicular cancer!

Some of you are quite familiar with our Advisory Board member Richard Wassersug, an internationally recognized expert on androgen deprivation therapy in men. Richard is a research psychologist, and last year we connected him with Peggy Miller at the Male Breast Cancer Coaliton who moderates our Men’s Breast Cancer virtual group.  They and others are pursuing a study on how male BCa patients respond to the word ‘survivor’. In Richard’s words:

(Peggy), I and others are collaborating on a survey study right now about how male breast cancer patients respond to the label “survivor”.  As you may know, female breast cancer patients overall like that label. In contrast, prostate cancer patients typically do not.  We hope to finding out whether this difference is due to a differences in how the two diseases progression and how they are treated, or instead reflect a fundamental sex/gender difference.

We’ve already collected data on about 70 male breast cancer patients, but we hope to double that.

Richard published an essay in Quilette late last month on male breast cancer “Masculinity, Emasculation, and Breast Cancer in Men”…. you’ll find it here. If you are not too familiar with this condition, it has every right to be considered a rare disease based on the number it afflicts ….. although, as Richard points out, male BCa kills more than testicular cancer! Read and learn ….

CancerCare Workshops: March 16 – Apr 30

CancerCare Workshops: March 16 – Apr 30

Leading Experts Discuss Important Cancer Topics
Make sure you’ve signed up for our upcoming Connect Education Workshops! These free workshops provide the latest cancer information straight from leading experts, via phone or online. At the end of the workshop, you’ll have a chance to ask the experts your own questions.
4/23    Update on Glioblastoma in Adults       
Anxiety and Prostate Cancer – an online presentation from Weill Cornell Medicine

Anxiety and Prostate Cancer – an online presentation from Weill Cornell Medicine

The NYC chapter for UsToo has cancelled on-site meetings and is inaugurating an online and dial-in event, accessible via computer, smartphone or telephone dial-in.  If interested, please see their instructions below from the UsToo Steering Cmte.  The mtg is scheduled to start at 6pm, Eastern, this Thursday, March 19.

______________________________________________________________________________________________
PROGRAM: Waiting for the Other Shoe to Drop: Anxiety and Prostate Cancer

Guy Maytal, MD
Chief of Integrated Care and Psychiatric Oncology, Assistant Professor of Clinical Psychiatry, Weill Cornell Medicine

How to access the meeting:

You can access our March meeting several ways. The best way to hear the program and see the presenter’s slides is to go online from your computer (if you have Chrome that is the best browser to use for this).
 
First click on the following link:
 
https://zoom.us/j/498180826?pwd=eDlGbjJOUE82VmRabE5STitSb0hMUT09
 
If you are a first time user of Zoom you may get to a page that says “Launching” but nothing seems to happen. If so, there should be a “click here” link if nothing further happens. Once you click on this you should be given a choice to run the application from your browser (Chrome works best). When you do that you should get a screen with the password filled in and asking for your name. Fill in your name and click JOIN to enter the conference.
 
Once you are in, there will be another prompt to join audio by computer or telephone. If you choose computer audio and it doesn’t work, look for the microphone icon on the lower left and to the arrow to the right of it. Click the up arrow and choose “audio options” and then select the “phone call” option and follow instructions. If that doesn’t work leave the meeting and re-join the meeting using telephone for audio. As long as you are on by computer you will see the speaker slides.
 
If you have a smartphone you can also access the conference by downloading the Zoom app and clicking on the link above.
 
If you cannot use your computer or smartphone to access the conference, you can participate via straight dial in with this number: 1 646 558 8656 and be able to at least hear the presentation. The meeting ID is 498 180 826
 
The bottom of the screen has buttons to mute your audio or turn off your video, as well as chat with the group. To see all buttons you may have to click on the more button.

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 03/16/20

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 03/16/20

PLEASE NOTE – for reasons best known to GtM, we only have audio this week. Nor does there appear to have been any use of the Chat Window.

Editor’s Pick: LHRH drugs and mental anguish – a topic near and dear to my heart. I consider myself fortunate to have known ‘The Black Dog’, as Churchill called depression, before I went on Lupron. That was a blessing for me in that it was much esier for me to handle and absorb. My heart goes out to men who suffer depression &/or anxiety with no prior experience. (rd)

Topics Discussed:

condolences to Jim Ward; who’s at risk from COVID-19?; low PSA, soft -tissue PCa endures for 20 years; multiple treatments at one hospital visit; LHRH drugs cause anxiety and depression; medical marijuana; radiating the prostate in advanced disease; with recurrence, at what PSA level should you scan?; frequency and type of scans to monitor advanced disease

CancerCare Workshops: March 16 – Apr 30

AnCan Virtually Arrives!!

In the dim, distant past of 2011, or was it 2012, I had just been kicked out the support group I co-moderated by a very insecure lead. Rather than the one-on-one interview style he practiced that made the large, weekly group feel they were eavesdropping on a private conversation, I worked hard to promote conversation and bring everyone into play. If the back-and-forth developed a life of its own, moderation was successful. Like a tugboat, moderators could just nudge a little here and there to keep discussion on track while sprinkling information and education into the wake.

So when a good buddy of mine suggested we start an online TV channel, I took him seriously. My friend had been in the virtual meetings world pretty much since inception and encouraged me to explore. I, however, had no interest in talking at an audience – I wanted to converse and interact with it. Support groups were much closer to my virtual ideal than a TV Channel. Moreover, virtual support groups tackled three issues where physical groups got a resounding ’F’.

  • Geographical ‘disabilities’ were removed – no one was restricted by distance or remote location
  • Physical disabilities evaporated – everyone could join no matter their state of mobility
  • Social disabilities faded – those who felt uncomfortable in a physical group or suffered from agoraphobia could attend, and those who were just plain shy could ‘lurk’.

To my amazement in 2012, I found only two (2) virtual support groups on the world wide web; one for post-partum depression, and the other for dieting. In the two-dimensional virtual world of written forums, there were options and I quickly became a celebrity. By providing solid experience and guidance – never medical advice!! – many sought my input. Then I discovered a telephone support group based out of the northern Midwest …. and from thereon history was made.

As possibly the first peer-led support group for any condition, I turned what originated as a men’s psycho-social support come drinking club into a bona fide, condition driven, virtual support group. By advertising on the written group forums, attendance grew rapidly. We went from one to two monthly meetings. Then we split the group by severity of disease – newbies did not want to be chatting with those suffering advanced disease. And soon we had to split again as numbers exceed 30+ participants per group. Within a couple of years, we had four then six groups each month; and, we received endorsements and co-sponsorship from a major support and education non-profit.

The phone platform also seemed inadequate just as virtual platforms became affordable. No longer did you have to commit thousands of dollars to host on WebEx when GoToMeeting and then Zoom catered to the individual consumer.  Adding visuals created yet another dimension, bringing the virtual support group experience even closer to a physical meeting. Video was always optional, and you could join by phone as well as online – we strove to maintain the lowest barriers to entry. And our meetings were always free and drop-in … no registration required.

Gradually our moderators learned best practices – how to keep a meeting moving; how to avoid people talking over each other; how to listen’; how to bring everyone into the virtual group discussion.  In 2016, our vision got formalized when we founded a non-profit, Answer Cancer Foundation, starting with the six groups then in existence. While all for one condition, my vision was much wider.

We knew that if it worked for the condition we were living with, this same experience could work for other illnesses and conditions …. especially for rare diseases where even in the best circumstances gathering a physical support group was challenging. And for conditions beyond cancer …. and for more than just those living with the condition – like caregivers. In 2019, Answer Cancer Foundation became AnCan as we launched a multiple sclerosis group. And as I write today, we host more than 20 meetings each month for cancer and non-cancer. We are proud to offer two virtual groups for rare diseases, and about to introduce new virtual meetings for blood cancers, and for ovarian cancer.

So here we are in 2020, in the midst of a global pandemic living within the parameter of social distancing. Many are suddenly recognizing the value of virtual meeting places. Some, like my nemesis the lead moderator mentioned in the first paragraph, had the audacity to tell a telcon of support group facilitators last week, that Zoom is inexpensive and everyone’s answer; he had tried it for the first time earlier in the week. I could not resist piping up that AnCan currently hosts nine (9) virtual meetings per month just for our cancer; that we have been doing so for eight years with our co-sponsor who, by the way, was hosting the telcon; and, that we would be delighted to share our know-how with anyone that needed help. And oh yes … that GoToMeeting offered a free room over the next 3 months for anyone that needed!

New MS Patients Show Cognitive Changes Regardless of Race

New MS Patients Show Cognitive Changes Regardless of Race

AnCan now serves more communities than just cancer, and certainly a lot more than the community with which we started – prostate cancer. That said,  we are delighted this week to have just expanded to include blood cancers and ovarian cancer.

Our vision was always to reach out to conditions that compromised mobility, so starting our Multiple Sclerosis group last Fall was a milestone. Personally, I know little about MS but am learning slowly especially from lurking in the MS Virtual Group as we train the moderators – although their success may make that redundant very soon!

This article on Medpage Today caight my eye …..it points out that compromised cognition is one of the first signs of MS. It also mentions that disease progression is observed as more rapid in non-caucasian ethnic groups.

AnCan encourages our MS readership to sign up to our blog and submit posts to help educate us all!

CancerCare Workshops: March 16 – Apr 30

Is there an elephant dancing around Howard Wolinsky’s latest article?

Our Advisory Board Member, Howard Wolinsky’s latest article on Medpage Today tiptoes around a very sensitive issue while making an excellent point. Place a bunch of different medical specialties in the same room to make a decision, the so called MultiD Approach, and you go a long way to neutralize a factor that can often act against patients’ best interests.

There’s an elephant gambolling through Howard’s article, acknowledged but not mentioned in so many words … and here’s the clue. The ‘MultiD’ approach appears to be restricted to Centers of Excellence and Medical Institutions where, as Dr. Kuban mentions – she doesn’t get paid for each patient she sees!

We are talking “financial conflict of interest”. That’s the same bad actor lurking in the background and chuckling as it gets the PSA test rather than the physician blamed for ‘overtreatment’. How often do you hear a community urologic oncologist recommending radiation – or a community radiation oncologist pushing surgery? These practitioners understand each others specialties and their side effects well enough, so it’s tough to buy the argument that it’s because they know their specialty best. Here at AnCan we would argue it’s because these docs  earn more money by treating the man themselves – the patients’ interests get subordinated to the doctors’ pockets.

AnCan totally endorses the MultiD Approach – but wonders how it will ever be implemented outside the salaried environment of large medical institutions and Centers of Excellence??.

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 03/16/20

High Risk/Recurrent/Advanced Prostate Cancer Virtual Group recording – 03/10/20

Editor’s Pick: Does cancer compromise your immune system – surprisingly there is debate!

Topics Discussed

Starting LHRH on recurrence; Intermittent Hormone Therapy; Darolutamide; Chemo vs 2nd Line Anti-androgen; getting PET scans approved; give abiraterone time; CARD trial – Jevtana; abi monotherapy?; drinking water reduced creatinine; does cancer compromise your immune system?; adding surgery to RT + ADT; questions for rad onc on starting salvage radiation

Chat Log 

AnCan Barniskis Room (to Everyone): 4:13 PM:

https://www.urotoday.com/video-lectures/mcrpc-treatment/video/mediaitem/843-embedded-media2017-10-09-16-50-00.html?utm_source=newsletter_4869&utm_medium=email&utm_campaign=navigating-the-course-of-treatment-new-findings-meet-old-habits-findings-from-latitude

PCRI goes VIRTUAL for its Mid-Year Update Conference

PCRI goes VIRTUAL for its Mid-Year Update Conference

For our prostate cancer followers, patients & caregivers, PCRI announced yesterday that its mid-year one-day conference on Saturday, March 28 will now be held as a virtual gathering with a live FREE stream …. all you need do is register here.

The conference features as always the dynamic variety duo, Drs. Mark Moyad and Mark Scholz. They will be joined by 3 excellent speakers:

  • GU Medical Oncologists, Dr. Evan  YU from Seatle Cancer Alliance/ University of Washington Med School
  • Radiation Oncologist, Dr. Jeffrey Demanes from UCLA
  • Genomic specialist, Dr. Joannne Wiedhaas, UCLA

Each speaker will be followed by Q&A fielding your written questions that can be submitted ahead of time. And it will conclude with 90′ of Q&A with Moyad & Scholtz.

This is a terrific opportunity for you to ask the experts all those questions your own medical team has not answered completely and/or we are not fielding in one of our NINE, yes 9!, monthly VIRTUAL PC support groups. AND this crew will respond to personal situations and provide somewhat filtered medical advice that we cannot do.

That should cover it all, but just in case not, here again is the PCRI Conference website:

https://pcri.org/2020-midyear-update#myu-speakers-topics

See you there … O&U, rd

CancerCare Workshops: March 16 – Apr 30

First Person Thoughts on Cancer & Covid-19

Like many of you this week, I have been reading multiple articles about how the corona virus may effect those living with cancer and how best to protect ourselves. Many of us who did not take this threat too seriously 3 weeks ago, are now reevaluating although I remind everyone that it may be no worse than the influenza threat that kills many each year – albeit we don’t read about it daily. WHO estimates between 250,000 – 650,000 die from influenza annually.

Amongst several articles that are in my inbox, I have a couple of first hand experiences. The first is from Shira Zwebner, a regular contributor to the CURE website, that you’ll find here; and the second is by our Board Chair Peter Kafka, reprinted from his meeting reminder to the virtual group Peter moderates. (rd – apologies for all the typos first time around; forgot to proof!!)

What A Difference A Week Makes

All of the sudden the world is thrust into a new paradigm in reaction to the onslaught of the Covid-19 coronavirus.  I suspect that many of us can tell stories about how our lives and communities are already being impacted by this new threat.  It looks like we are all in for quite a ride for some time to come.  Some might discount these events or downplay the seriousness of the virus, but it can’t be denied that there is an overriding sense of fear and anxiety in many quarters.

How does this relate to those of us dealing with cancer?    Oddly enough there are many crossovers and “take homes”.  Who among us did not feel fear and anxiety and a sense that our world as we had known it was coming to an end when we were first diagnosed with this cancer?  I know for myself that fear was a dominant feeling.  Because it was all so new and I was unprepared and uninformed my emotional response was quite out of control.  Fortunately, I found support quickly and was led to experts in the field who could set me on a steady course and explain exactly what was going on and help put things in perspective.

Most of us have found that our worlds did not completely fall apart.  Yes, many things may have changed – they certainly have for me and those closely around me.  But life has gone on and adjustments have been made.  We humans are remarkably resilient creatures and can adapt to amazing challenges and circumstances.  For myself, I have just embarked upon a heavy-duty regimen of chemotherapy for my aggressive advanced prostate cancer.  Perfect timing to put myself into a situation where my immune system will be further compromised by the chemotherapy infusions.  And what a time to have to show up at our local hospital every three weeks for a day of infusions.  So much for my luck.

I guess I am one of the lucky ones who has jumped to the head of the line in the high-risk category for dying from Covid-19 Coronavirus, over 70 years old with cancer and a compromised immune system.  But somehow, I am just not over consumed by this thought at the moment.  I am not going to be cavalier and take stupid risks, but I can really only deal with one big threat at a time and for me it happens to be the prostate cancer.  I think my ongoing 6-year journey with this disease has put me in a mindset of preparedness.  Fear is no longer driving my decisions and actions.  Understanding and intelligence rule the day for me.